Genomic analysis re-classifies breast cancer into new subtypes

Written by Jenny Straiton, Future Science Group

Baculovirus Transduction of Human Mesenchymal Stem Cells

Photo credit: Volha Vshyukova A novel statistical tool that identifies the genetic and molecular patterns of tumors offers a more reliable prediction of the clinical trajectory of an individual’s breast cancer, including if, and when, it could come back. Cancers are usually named after the place in which they originated; however, due to the complexity of the disease and the variety of treatment options and outcomes, this may no longer be enough. Research has found that breast cancer alone can be split into 11 different subgroups, each with separate clinical trajectories. Delving deeper into the genetic and molecular make-up of individual...

To view this content, please register now for access

It's completely free